A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates
J Virol. March 2025
Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants
J Virol. March 2025
Pandemic risk stemming from the bovine H5N1 outbreak: an account of the knowns and unknowns
J Virol. February 2025
Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the Covid-19 Pandemic”
Influenza Other Respir Viruses. October 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamsters
Vaccine. October 2024
A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria
Science. September 2024
Influenza B Virus Receptor Specificity: Closing the Gap between Binding and Tropism
Viruses. August 2024
Establishment of Swine Primary Nasal, Tracheal, and Bronchial Epithelial Cell Culture Models for the Study of Influenza Virus Infection
J Virol Methods. June 2024
A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
eLife. May 2024
Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models
Viruses. March 2024
Swine influenza A virus isolates containing the pandemic H1N1 origin matrix gene elicit greater disease in the murine model
Microbiol Spectr. March 2024
A general computational design strategy for stabilizing viral class I fusion proteins
Nat Commun. February 2024
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses
Cell Rep. July 2023
Malaria disrupts the rhesus macaque gut microbiome
Front Cell Infect Microbiol. January 2023
A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection
Front. Immunol. December 2022
Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis
PNAS Nexus. November 2022
Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999-2018
Clin Infect Dis. January 2022
Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018
Open Forum Infect Dis. January 2022
Vaccine-Induced Protection in Two Murine Models of Invasive Pulmonary Aspergillosis
Front. Immunol. May 2021
